Back
Latch, Inc. Vs. Rigel Pharmaceuticals, Inc. Industry Stock Comparison
Sell
36
LTCH
Latch, Inc.
Last Price:
$0.13
Seasonality Move:
-11.96%
Buy
71
RIGL
Rigel Pharmaceuticals, Inc.
Last Price:
$41.66
Seasonality Move:
4.89%
Sell
36
Latch, Inc. (LTCH)
is a Sell
Is Latch, Inc. a Buy, Sell or Hold?
-
The current Latch, Inc. [LTCH] share price is $0.12. The Score for LTCH is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
LTCH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Rigel Pharmaceuticals, Inc. (RIGL)
is a Buy
Is Rigel Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rigel Pharmaceuticals, Inc. [RIGL] share price is $40.78. The Score for RIGL is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
RIGL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LTCH Stock Price Chart
What is Latch, Inc.'s stock price today?
-
The Latch, Inc. share price today is $0.12The current trend is relatively stagnant and LTCH is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals, Inc.'s stock price today?
-
The Rigel Pharmaceuticals, Inc. share price today is $40.78The current trend is moderately bearish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
LTCH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 47.93 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.11 - 0.13) | Sell |
| Bollinger Bands (100): | (0.1 - 0.14) | Sell |
RIGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.38 | Buy |
| Relative Strength Index (14 RSI): | 46.83 | Sell |
| Chaikin Money Flow: | -394915 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.38 - 48.28) | Sell |
| Bollinger Bands (100): | (27.42 - 42.68) | Buy |
LTCH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.13 | Sell |
| 20-day SMA: | 0.13 | Sell |
| 50-day SMA: | 0.12 | Buy |
| 200-day SMA: | 0.13 | Sell |
| 8-day EMA: | 0.13 | Sell |
| 20-day EMA: | 0.13 | Sell |
| 50-day EMA: | 0.12 | Sell |
| 200-day EMA: | 0.16 | Sell |
RIGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.16 | Sell |
| 20-day SMA: | 45.41 | Sell |
| 50-day SMA: | 36.82 | Buy |
| 200-day SMA: | 27.15 | Buy |
| 8-day EMA: | 43.32 | Sell |
| 20-day EMA: | 43.28 | Sell |
| 50-day EMA: | 39.32 | Buy |
| 200-day EMA: | 29.68 | Buy |
Latch, Inc. Earnings Growth & LTCH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rigel Pharmaceuticals, Inc. Earnings Growth & RIGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.13 per share, and a decrease next year of $2.31 per share.
Latch, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rigel Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||